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ABSTRACT 
APPROXIMATE DYNAMIC PROGRAMMING FOR ANEMIA MANAGEMENT 
Mehmet K. Muezzinog1u 
Apri112, 2006 
The focus of this dissertation work is the formulation and improvement of anemia 
management process involving trial-and-error. A two-stage method is adopted toward this 
objective. Given a medical treatment process, a discrete Markov representation is first de-
rived as a formal translation of the treatment process to a control problem under uncertainty. 
A simulative numerical solution of the control problem is then obtained on-the-fly in the 
form of a contro11aw maximizing the long-term benefit at each decision stage. 
Approximate dynamic programming methods are employed in the proposed solu-
tion. The motivation underlying this choice is that, in reality, some patient characteristics, 
which are critical for the sake of treatment, cannot be determined through diagnosis and 
remain unknown until early stages of treatment, when the patient demonstrates them upon 
actions by the decision maker. A review ofthese simulative control tools, which are studied 
extensively in reinforcement learning theory, is presented. 
Two approximate dynamic programming tools, namely SARSA and Q-learning, are 
introduced. Their performance in discovering the optimal individualized drug dosing pol-
icy is illustrated on hypothetical patients made up as fuzzy models for simulations. As an 
addition to these generic reinforcement learning methods, a state abstraction scheme for the 
considered application domain is also proposed. The control methods of this study, captur-
ing the essentials of a drug delivery problem, constitutes a novel computational framework 
for model-free medical treatment. 
tV 
Experimental evaluation ofthe dosing strategies produced by the proposed methods 
against the standard policy, which is being followed actually by human experts in Kidney 
Diseases Program, University of Louisville, shows the advantages for use of reinforcement 
learning in the drug dosing problem in particular and in medical decision making in general. 
v 
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Trial-and-error is a fundamental component of reasoning. The role of this heuristic 
in animal learning has been first conjectured rigorously by Edward Thorndike in (Thorndike, 
1911) by the Law of Effect. His view initiated a mainstream approach in learning theory, 
namely Reinforcement Learning (RL), as the prominent alternative to the Pavlovian expla-
nation. His approach suggests that developing a strategy to cope with the environment is 
possible due to two characteristic features: First, this form of learning is selective, as the 
learning system selects an action among alternatives towards a goal. Second, it is associa-
tive as these alternatives are corresponded to particular situations. 
Mimicking trial-and-error learning in animals constitutes a major challenge in arti-
ficial intelligence (Russell and Norvig, 2002). Due to the external information gained by an 
agent, the learner, along its interactions with its environment, this form oflearning has long 
been confused with supervised learning, the environment being considered as the supervi-
sor, in artificial intelligence literature. In fact, an external supervision telling the agent what 
to do explicitly barely exists. It is true that there is a signal available for the agent incurred 
upon each decision, and this signal is really correlated to the agent's performance upon 
each interaction. However, unlike in conventional supervised learning, it does not convey 
an example for the learner. Observing such a signal gives rise to a non-trivial internal eval-
uation in the agent, involving learning lessons from its previous choices and reflecting this 
gained experience in planning pragmatically its future. Due to this distinctive effort, mod-
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em approaches in artificial intelligence study trial-and-error learning exclusively under the 
category of RL. Another computational aspect differing RL from conventional supervised 
learning schemes, which have been founded on Newtonian methods and gradient descent 
iterations, is that RL is applicable on dynamic and stochastic problems very effectively. 
With its computational roots fed by the theory of stochastic approximation (Benveniste 
et aI., 1990), RL has developed into a major research field in computational intelligence for 
more than two decades (Barto et aI., 1983; Kaelbling et aI., 1996). 
Formally, the process of trial-and-error is a systematic way of eliminating non-
beneficial attempts in a learning task, thus is strongly linked to the computational frame-
work of Dynamic Programming (DP) studied in control theory (Bellman, 1957) and also 
in theoretical computer science (Baase and van Gelder, 1999). However, for this powerful 
methodology to be directly applicable, a critical piece of information, namely the exactly-
quantified utility of each possible action at each situation that the learning system can ever 
encounter, is essential (c.£ the association feature oftrial-and-error). Unfortunately, these 
data become available in many real-life applications only after sufficient amount of inter-
action of the learning system with its environment. For example, in order to apply the 
Dijkstra algorithm, a popular shortest-path solver employing DP ideas, the complete graph 
information in the form of nodes and arc lengths is required in advance. In many learning 
tasks, however, it is too optimistic to expect that complete information be available to the 
learning system in advance. To solve the shortest path problem under such a constraint, the 
learning system would have choice but to explore both the nodes and the arcs of the graph 
by a number of trials, most of them leading possibly to non-optimal solutions. The infor-
mation gained by exploring the graph is stored in the DP table on-the-fly, i.e. in parallel 
with the solution. 
The initial lack of information about the problem, which hinders or simply blocks a 
direct DP solution, has given rise to Approximate Dynamic Programming (ADP) methods, 
which combine the simulation-based information gathering techniques and the well-posed 
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DP methods. The author's interest in the approximate dynamic programming is due to the 
observation that they have been remarkably successful in overcoming real-life multistage 
decision making problems under uncertainty, yet employing simple mechanisms (Connell 
and Mahadevan, 1993; Tesauro, 1995; Barto et aI., 1995; Bertsekas and Tsitsiklis, 1996). 
Another (and the most celebrated) characteristic of ADP is its utilizing a parametric 
approximator to summarize the DP table, the only means for storing gained experience 
during the entire solution process. This crucial set of information grows to unfeasibly 
large sizes as the dimension of the state space is increased linearly. In particular, its size 
is an exponential of the state-space dimension, a phenomenon addressed in the computer 
science jargon as the curse of dimensionality. To maintain tables cursed by dimensionality, 
they are typically parameterized in ADP framework by a reasonable number of variables, 
which converts the conventional DP solution from DP table updates to parameter updates at 
each solution stage. As parametric universal approximators, feedforward neural networks 
are primarily employed in ADP solutions for this purpose. 
A majority of medical decision making instances have traditionally been based on 
trial-and-error, which aims at keeping certain patient variables quantified by (possibly er-
roneous) measurements. The basic motive that validates the trial-and-error heuristic in this 
process is the difficulty in (or in many cases simply the impossibility of) modeling the 
patient. Therefore, a medical process is sometimes a model-free control task subject to un-
certainty, thus cannot be handled by the classical control theory, which assumes typically a 
given plant on which the control designer can rely to a certain extent. 
Drug administration in chronic conditions is a typical recurrent trial and error pro-
cess: A physician selects an initial drug dose based on a standard reference and observes 
the patient for specific response and/or side effects. Following the observed state of the 
patient, the dose is adjusted to improve the response and/or to minimize dangerous side 
effects. The adjustment continues until a desired response is achieved. Here the physician 
can be viewed as an agent performing goal-oriented learning. 
3 
Scope and Contributions of This Study 
This thesis work reviews ADP tools to reveal their applicability in medical treatment 
processes, which involve inherently tria1-and-error heuristics. An automated procedure that 
is applicable on certain treatment instances constitutes the broader objective of this study. 
To achieve a valid formulation and optimal control of a given treatment process, a 
two-step procedure is implemented in this work. 
1. Translating a given treatment process into a Markov Decision Problem (MDP) consti-
tutes the foremost challenge towards solution. This includes quantifying and quan-
tizing the control variables as well as declaring internal state variables and all in-
puts/outputs of the considered system. Another essential task performed at this step 
is the introduction of reward formulation in order to reflect the high-level control ob-
jective to rank the state transitions and underlying control actions. It is important to 
discriminate this phase from conventional modeling procedures for control (Astrom 
and Wittenmark, 1989), where the system dynamics need to be delineated in the form 
of a legitimate state representation. 
2. Having obtained a MDP formulation for the considered treatment, the second step 
is selecting and customizing an ADP method to extract actions that maximize the 
cumulative reward. This method operates on sample trajectories actually generated 
by the patient and is assumed to have access to the patient in order to demonstrate 
actions and observe their consequences. Based on these observations, the learning 
system of interest ranks the states and the control actions based on their utility with 
respect to the ultimate control goal. In some cases, this is even achieved in real time, 
together with the actual system operation by evaluating the consequences derived 
from the samples, which are generated under the control of the learning system itself. 
In other words, the considered framework enables carrying out both learning and 
control simultaneously. This second phase of the procedure involves particularly the 
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temporal difference methods of ADP augmented by connectionist approximators, 
particularly Radial Basis Function (RBF) networks that implement the control law 
being developed online as a locally parameterized input-output relation. 
This study views the broad field of medical treatment under a fundamental assump-
tion, namely the process' compatibility with the MDP framework. In particular, the meth-
ods of this study are applicable on treatment processes which can be accurately accommo-
dated in a fully-observable Markovian domain with well-defined finite sets of states and 
actions. The scope of this work is limited also by fictitious patients implemented on digital 
computers that are believed to be mimicking real patient behavior in the considered prob-
lems. Consequently, this study does not claim any direct contribution to real-life treatment 
of any kind, although some practical concerns will be addressed in experiments, to an ex-
tent that they can be reflected in the design of virtual patients. Extensions of ADP-based 
methods in medical treatment are left to succeeding studies aiming primarily a safe clinical 
practice of trial-and-error heuristics. 
A drug-dosing problem, namely anemia management is selected as the test bed for 
the methods adopted and/or developed in this study. All experimental results reported in 
this work address this problem described briefly and formulated in the following chapters. 
The experimental findings are due to a joint effort maintained with the Kidney Diseases 
Program, University of Louisville, which contributed to this work by providing the med-
ical background, specifics of the benchmark problem, and continuous feedback. A par-
ticular contribution of this work, which has yet become the subject matter for (Gaweda 
et aI., 2005e; Gaweda et aI., 2005b; Gaweda et aI., 2005a; Gaweda et aI., 2006a), is a 
computational ground for the trial-and-error heuristics in anemia management. The author, 
however, would like to stress at this point that having focused on this particular problem 
should not constrain the validity of the general two-stage approach to the selected test bed. 
Among other model-free control approaches in medical decision making, which are 
much smaller in number as compared to model-based methods (Khoo, 1999), this study 
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constitutes apparently the pioneering attempt in utilizing approximate dynamic program-
ming for treatment purpose, although its outcomes are regarding only the virtual patients 
currently. 
Outline of the Dissertation 
An introduction to Markov Decision Processes is made in the following chapter. 
Staged decision making terminology is presented together with examples illustrating how 
real-world problems are accommodated in this framework. A minimum set of conditions on 
the considered problem to achieve such an accommodation are listed therein. The practical 
value of this set is of utmost importance since it actually draws the crisp boundaries for the 
(medical) decision problems that can be handled using the general strategy of this study. 
Chapter II presents also the conventional Dynamic Programming methodology, an elegant 
solver for MDP, and a discussion of its limitations. Alternative simulative sub-procedures, 
which are compatible with the general DP strategy but capable of eliminating the demand 
for complete information about the process, are brought to the reader's attention. The role 
of parametric approximators in realizing these flexible solutions is finally explicated in 
Chapter II. 
Chapter III sets the test bed of this study. The problem of Anemia Management is 
introduced and formulated within the MDP framework. As a critical component of ane-
mia management, the patient response is described and possibilities of mimicking a real 
patient's behavior are discussed (although the primary motivation of this work is, indeed, 
avoiding the modeling process). A fuzzy patient model is advocated as a virtual patient 
that can sufficiently demonstrate critical features of a real patient with reasonably simple 
parameter adjustments. This model constitutes the object of the computing experiments 
presented in the remainder of this document. 
Chapter IV is devoted to customization the two ADP methods, namely SARSA and 
Q-learning for anemia management. The performances of these approaches are evaluated 
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experimentally on virtual patients with diverse response characteristics. A statistical com-
parison of the methods is also provided therein. 
Chapter V proposes and implements a state abstraction scheme based on an inherent 
feature of the valid dosing strategies for anemia patients. In particular, the monotonicity of 
a valid dosing strategy with respect to patient variables is utilized to extend the reasoning 
triggered by observing a state transition in the patient to other (and possibly yet unobserved) 
states. This constitutes an illustration of utilizing problem-specific information in reducing 
the computational demands drastically. It is shown with extensive simulations that such 
an abstraction can substantially improve extraction of the optimal dosing strategy using 
trials. Improvement on the performance due to incorporating the suggested mechanism to 
the previous approaches is also accounted for. 
Conclusions and selected future research directions motivated by this work are high-
lighted in Chapter VI. 
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CHAPTER II 
DECISION MAKING IN STAGES 
This study deals with problems where decisions are made in stages. This chapter 
describes a constructive framework to handle such problems, including many medical treat-
ment instances under reasonable assumptions as formulated in the following chapters. The 
considered framework stands on two legs: A Markovian setting to cast the given decision 
problem - the representation, and a DP-based methodology - the solver. 
In what follows, the representation is introduced together with the basic probabilis-
tic notions. Dynamic programming methodology is then based on these notions. Some 
computational limitations of conventional DP approach are highlighted and alternative pro-
cedures are introduced. 
Markov Decision Problem 
Finite-State Stationary Markov Chains 
Markov Chains (MC) is a unique representational domain for dynamical behavior. 
It adopts the elementary concept of state in system theory: the summary of the past that 
acts on the future. MC representation is applicable on (time-indexed) processes, which (i) 
occupy one and only one state at any given time and (ii) possess the essential Markovian 
property: the necessity and sufficiency of quantifying state variables at a fixed time to in 
producing their values in any future time t > to. 
An MC consists of a countable set S of states, which are usually enumerated by 
positive integers: S = {l, 2, ... , N}. Although N may be infinite, the case where it is 
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finite, i.e. the finite-state MC, is of special interest. 
The key idea ofMC representation is treating the evolution of states of a dynami-
cal process as a discrete-time! sequence of random variables {xd~o on 8, Xo being the 
initial state.2 This sequence (also called a trajectory) is assumed to be demonstrating the 
Markovian property and is governed by an N x N state transition matrix P[k], where the 
component Pij [k] denotes the probability that, given the current state is i, the following 
state will be j at time instant k: 
(1) 
This interpretation implies clearly that P[k] is a stochastic matrix for all k: 
Definition 1 A square matrix P is said to be stochastic matrix if all its elements are non-
negative and the sum of the elements on each row is equal to 1. 
The final (yet the most restrictive) assumption of this study regarding MCs is that 
the state transition probabilities governing all dynamics are time-invariant: P[k] = P. 
Definition 2 Afinite-state stationary Markov Chain is a Markovian process given the two-
tuple M = (8, P), where 8 is the finite state set and P is the stochastic matrix inducing 
dynamics by providing the transition probabilities. 
Note that (8, P) is an alternative to the conventional state representation, which 
is praised by the classical dynamical system and control theories for providing system 
analysis and design efforts with powerful tools of linear algebra and functional analysis. 
In fact, the state equations of a discrete-time dynamical process, with an input sequence 
specified, can always be considered as a declaration of the general term of a sequence, 
1 There are also continuous-time Markov processes. The word chain is reserved here for the discrete-time 
case, which is assumed throughout this study. 
2 As a note on notation, the time index k can be appended to a variable x either as a subscript Xk or as 
x[k], whichever is appropriate in the current context. 
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reducing the representation to an Me. In other words, it is always possible to switch from 
a given state representation to an equivalent and unique Me. On the other hand, the reverse 
direction does not always exist, i.e. it may not be possible to obtain a state representation 
that governs the dynamical system exactly in the same way as a given Me. Therefore, the 
generic Me representation has a broader scope than the state representation in the sense that 
Me is capable of accounting for stochasticity that might be involved in state transitions in 
an explicit way, by means of the state transition matrix. 
The Markov chain, even with the assumptions of stationarity and finiteness stand-
ing, is not only capable of accommodating a fairly broad class of dynamical processes but 
also brings novel solution techniques to the dynamical systems domain, especially when 
there is no state representation available. As will be demonstrated in this study, it is even 
possible to extract a partial Me representation of a stochastic system and still achieve a 
certain qualitative performance measure. Moreover, these two can be performed simulta-
neously. These useful features ofMes are shared by conventional state representation only 
in very special cases, e.g. in the case of state equations involving additive and Gaussian 
nOIse. 
Markovian Processes Driven by Decisions 
Staged decision processes in Markovian setting form a critical class of dynamical 
systems for modern engineering sciences. There are two characteristic features of these 
generally stochastic processes. First, the state transitions occur due to an external effect, 
called action. In particular, an action is assumed to be applied by a decision maker as an 
input to the process at each transition and has a non-neglectable effect on the determination 
of the next state. In a Markovian setting, the next state is produced not only by the current 
state but also on the action applied. The other characteristic of staged decision processes is 
that upon each state transition an immediate consequence is incurred. In real-life problems, 








xk-l ,--- xk ,---
Action ak Action ak+l 
State 
xk+l 
Figure 1. Three stages of a decision process in Markovian setting. 
the preceding state. The reward (benefit) approach is adopted in this study. An illustration 
of a staged decision process including the actions and reward is given in Figure 1. 
Finite-state MCs from an extended perspective provide the necessary mathematical 
rigor and constitute a constructive representational domain for staged decision processes. 
Two additional components to the basic MC setting are required to capture the characteris-
tics mentioned above. 
The first addition is a component addressing the actions which the target process. 
This will be denoted by the finite set A augmenting M = (S, P): 
(2) 
which contains all possible actions that can be applied at each state. Note that, setting a 
single set A for all possible states does not really restrict the actions to be applicable on 
each state. In a valid decision process, it may well be the case that the decision maker faces 
two different sets of options of actions Ai and Aj for two different states i, j E S. In such 
cases, the global action set is determined as the union of applicable options, e.g. Ai U Aj 
in this example. 
The action a E A applied at state i E S can be viewed as specifying N probabilities 
regarding all possible transitions originating at i. From this perspective, the role of applying 
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an action for i among the elements of A is actually equivalent to picking uniquely the i-th 
row ofP from m possible candidates (each adding up to unity). 
Definition 3 Any function 7r(.) : 5 ---+ A mapping states to actions is called policy. 
Under the finiteness assumptions above, it is easy to see that there are 151 . IAI = 
N M possible policies associated with the process. 
Definition 4 A given Me M = (5, A, P) is said to be following a policy 7r if the decision 
maker always performs as the action 7r( i) at state i, for all i E 5. 
Note that specifying a policy to follow forces out the component A in the description 
of the process in the sense that there is no need to state the set of options A, once which 
option to pick is clearly stated. Specifying a particular 7r also fixes all rows of P, thus 
determining uniquely all state transitions. The MC on the policy 7r is therefore denoted by 
M7f = (S,P7f). 
The second addition to MC to handle decision processes is the real function 9 (., ., .) : 
5 x A x 5 ---+ a?, called the reward functional. The evaluation g( i, a, j) quantifies the imme-
diate consequence of taking the action a at state i and attaining j as the next state. Note that 
the considered reward formulation is compatible with the probabilistic nature of the pro-
cess in the sense that taking action a at state i may result in a variety of states along which 
the incurred reward may vary. Note that, when following a particular policy 7r, the reward 
function can be tabulated as an N x N matrix G7f, since the reward value is dependent only 
on i and j in this case: g(i, a, j) = 9 (i, 7r(i), j). 
Although the considered reward formulation is fairly general, there are two implicit 
assumptions underlying it: the functional g(., ., .) is deterministic and time-invariant. In 
other words, the same reward is ensured in all cases whenever state j occurs upon taking 
action a at state i, irrespective of the time this happens.3 The author would like to note at 
3This neither implies that state j always occurs when action a is taken at state i, nor that the action a 
must be taken at state i. 
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this point that these assumptions may be dangerously restrictive in casting some real-life 
problems, although they are accepted by the canonical problems handled in this study. 
Problem Statement 
Given a Markovian decision process M = (S, A, P, g) and an initial state i E S, 
the Markov Decision Problem (MDP) is defined over the policy space and is formally stated 
as follows (Puterman, 1994). 
Problem 1 Find the policy 7[* which maximizes the expected discounted sum of immediate 
(3) 
where the sequence Xo, Xl, ... , Xtf is produced by the chain M1f, a E (0.1] is a specified 
discount factor and the expectation is taken with respect to the probability distribution 
specified by the state transition matrix P governing the Markovian decision process. 
As stated formally in Problem 1, the MDP formulation seeks the optimal way of 
assigning actions to states that maximizes the accumulated immediate rewards over a spec-
ified time interval. The problem is stated for an arbitrary state i E S to be taken as the 
initial state of the decision process M1f. Note that, also implicit in this formulation is 
the sequence of states generated by M1f as a consequence of the optimal action sequence 
The kernel a of the power sequence that weights the immediate rewards is called 
the discount factor. This parameter ofthe decision problem tells to what extent the rewards 
due to future state transitions should contribute to the sum with respect to their distances to 
the initial state in time. The meaning of a < 1 is that future rewards matter to us less than 
the same costs incurred at the present time. The marginal case of a = 1 corresponds to the 
undiscounted case which sets the goal simply as maximizing the total reward accumulated 
over the specified time interval. 
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The problem is called an infinite-horizon MDP when t f ---t 00. This case induces 
the most general formulation. It addresses even problems with a terminal state, i.e. a goal 
state which finalizes the state transitions. In fact, such problems with a = 1 are called the 
(stochastic) shortest path problems. Analysis of these problems, which is skipped in this 
study, provides an foundation of the other types of problems accommodated by the infinite-
horizon formulation. The author recommends the text (Bertsekas, 2000) for an insightful 
treatment of this topic. 
The focus of this study will be on the discounted (a < 1) infinite horizon problems 
with a bounded reward function, i.e. g(., " .) ::; !vI < 00. In this case, the decreasing geo-
metric profile {ak M} makes J7r (i) well-defined for all 7r and i, thus a solution to Problem 
1 always exists in this case. These problems constitute the second level of generality in the 
classification ofMDPs and their solution methods are outlined in the following section. 
The remaining two classes of MDPs are classified by the cases where there is no 
terminal state, a = 1, and/or the reward g(',',') is unbounded. These types of problems 
are out of the scope of this study. 
Dynamic Programming 
Dynamic Programming (DP) is a methodology to solve MDPs. It was manifested in 
(Bellman, 1957) as a numerical solver. The presentation begins with a case study analyzing 
a discrete-time but continuous-state optimal control problem, namely inventory control. Al-
though the problem utilizes the common state representation, the material then extends the 
discussion and the algorithm's application field to general Markovian representations. Due 
to the mathematical rigor and the generality of the perspective achieved by Bellman in his 
text, DP is among the few engineering tools whose computational benefits and limitations 
have been known almost completely since their conception. 
The application field of DP, on the other hand, has grown enormously in the last 
five decades. Modem approaches to DP are no longer confined to the classical control 
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theory arguments, but rather evaluate it as a general class of heuristics that minimize non-
beneficial attempts in the solution of a staged decision problem, thus saving resources and 
time. Along its 50 years of history, numerous problems have been formulated and solved 
within this framework. There is a significant diversity among real-life engineering prob-
lems, especially in the broad field of operations research, where the only reasonable solu-
tions can be obtained by DP-based methods. 
It can be argued from an algorithmic point of view that DP methods balance the 
computational burden and the memory requirement in the solution of a problem in an al-
ternative way: DP provides generally a faster exact solution in contrast to other known 
heuristics, such as classical depth-first or breadth-first search strategies, at the expense of a 
larger amount of (dynamic) memory that also needs to be maintained. A typical example 
that demonstrates DP characteristics is the well-known Dijkstra algorithm (Baase and van 
Gelder, 1999), which computes shortest paths in a given graph. Along with its algorithmic 
aspect, there is a variety of interpretations ofDP and a voluminous literature on the analysis 
and synthesis of its methods. 
The key element of a DP-based solution procedure is the DP table, which contains 
values ofthe states already visited in the search space. A value is the unique measure of the 
benefit in including the associated state in the optimal trajectory, which would be generated 
by the optimal policy (i.e. the solution of MDP). The term dynamic refers to the updates 
on the DP table and the time-varying (usually growing) memory requirements to maintain 
this table along the solution, as the procedure explores all elements of the state space and 
ascertain their values. 
The formal definition of value has already been made implicitly in the MDP formu-
lation in (3): 
Definition 5 The value of state i in a Me following the policy 7r is evaluated by the value 
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function pr ( .) : S ---t ~R defined by 
J(i) ~ E { ~ a k . 9 (X" 1l'(Xk), Xk+1) Xo = i} . (4) 
Detennining the value function is a critical sub-goal in the DP strategy. Once the value 
function is known for each 7f, the remainder of the solution turns out to be picking merely 
the policy 7f* which maximizes J7r( i) evaluated attheprovided initial statei: arg maxp { JP( i) : 
P E II}, where II is the (finite) set of all possible policies. Therefore, in many applications, 
DP is viewed only as a method for detennining the value function only, although value 
iteration is only a part of its role in staged decision making. 
Principle of Optimality 
All DP strategies are based on the principle of optimality: 
Definition 6 Let 7f* be an optimal policy for the MDP in (3) and assume that when using 
7f*, a given state i E S occurs at time t > 0 with positive probability. Consider the 
truncated version initiated at k = t: 
(5) 
Then, the principal of optimality holds if and only if the policy 7f* is still an optimal policy 
for the truncated problem for all 1 ::; t ::; t f. 
The notion of this principle is intuitively very sound. Humans apply this principle routinely 
in making daily-life inferences such as: 
Since 1-64 is the shortest route from Louisville to Lexington and since this route passes 
through Fran~rort, then 1-64 is also the shortest route between Franlifort and Lexington. 
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The Dynamic Programming Algorithm 
Using the definition (4) of pro directly, one obtains 
J7r(i) = E {f ak . 9 (Xk' 1T(Xk), xk+d Xo = i} 
k=O 
E {g("O, 7[(XO), Xl) + ~ ak . 9 (Xk, 7[(Xk)' .T'+l) Xo = i} 
tp;; [g( i, 7[(i), j) + E { t, "k . 9 (x,. ,,(X,), X'+1) Xl = j } 1 
N 
LPij [g(i, 1T(i),j) + aJ7r (j)] , (6) 
j=l 
which relates the values of two consecutive states i and j in a given process. An immediate 
result that can be derived from (6) is that, if the values of all possible successors of a state i 
is known (or guessed), then the value of i can be exactly computed. Of course, the transition 
probabilities Pij are critical in this calculation and they are yet assumed to be known in the 
reasomng. 
Application of the principle of optimality on (6) then yields the crucial property of 
the optimal value function, namely J7r* (.) is a solution of N linear equalities involving N 
unknowns: 
N 
J7r* (i) = L [Pijg( i, 1T( i), j) + aJ7r* (j) ] ' i E S = {1, ... , N} (7) 
j=l 
called Bellman's equation. By adopting the matrix forms P and G for the transition prob-
abilities and the reward function, respectively, they can be written in the compact form 
,r* (1) J7r* (1) 
J7r* (2) 
= diag (PGT ) + aP 
J7r* (2) 
(8) 
J7r* (N) J7r* (N) 
where diag(·) functional gives the diagonal of its argument as a column vector. 
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The transition probabilities P driving the process and the rewards G are critical in 
this calculation. Once they are known, the solution to the evaluation problem is obtained 
by 
And once the states are evaluated in this optimal way, the solution to the MDP is extracted 
by 
n* (i) +- {a E A : a maximizes the probability Pw} (10) 
where j' is the index of maximum element of [ J"' (1) Jrr' (2) ... J"' (N) r. The 
resulting policy n* is clearly the desired one as it maximizes the chance of switching to the 
most beneficial state, maximizing the cumulative reward (3). 
There is a variety ofDP algorithms, each leading to the solution (9) iteratively. Their 
common approach is starting by the initial guesses of state values and a particular initial 
policy. This corresponds to initializing the DP table by these guesses, possibly randomly. 
The adopted initial policy may also be random, or a best-guess one based on the prior 
information on the considered problem. 
The solution procedure is a loop containing the two particular sub-procedures: 
a. Value Iteration The following two steps constitute the value iteration sub-
procedure ofDP. 
1. Apply the policy in effect and observe the next state and the incurred reward. 
2. Using the relation (6) between the values of new and previous states, the value ofthe 
new state in the DP table is updated assuming that the value of the preceding state 
was correct. 
Note that, in the light of the discussion above, performing these steps sufficiently many 
times on a fixed policy n is equivalent to numerically solving (6) for the exact values J7r (.). 
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h. Policy Iteration Note that any update on the DP table may result in an in-
consistency between the current status of the DP table and the policy that is being applied, 
and the value iteration is no exception. In other words, the policy in effect may no longer 
yield the most beneficial states with respect to the current values after performing the two 
steps above for any number of times. 
To achieve consistency between the policy in effect and the current content of the 
DP table, a policy iteration step is essential. This is achieved simply by applying (10) for 
each state, where, instead of pr> , one has now the current values J7r k represented in the DP 
table: 
1[k+l (i) t---- {a E A : a maximizes the probability Pij> } (11) 
where j* is the index of maximum element ofthe current DP table. 
The point where DP algorithms differ is actually the point where they perform the 
policy iteration step. The Gauss-Seidel iteration (Bertsekas and Tsitsiklis, 1996) for in-
stance performs policy update upon each value iteration step (i.e. right after Steps 2 above). 
Extracting the policy from the current DP table may alternatively be performed after a cer-
tain amount of repeating steps 1 and 2 within a loop. A third scheme may be iterating the 
policy upon encountering all states. 
This interaction between the policy in effect and the values in the DP table continues 
until both of them convergence. Under mild assumptions, including a < 1, all such proce-
dures can be shown to be really converging along iterations to a policy which is consistent 
with the limit values in DP table, where the limit policy is the optimal policy: 1[k -+ 1[* as 
k -+ 00. 
The general DP strategy outlined here constitutes the basis of the approximate meth-
ods, which will be utilized for the problems ofthe following chapters. 
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Limitations 
Despite theoretical guarantees on their convergence to an optimal policy, the com-
putational demands of DP solutions may be overwhelming. The obvious reason for this 
is that a DP algorithm handles the states individually and builds relations between their 
values. As a result, the number N of states is a direct parameter of the computational load: 
N real numbers in the DP table to be maintained, each requiring N(N - 1) additions (c.f 
(6)) in the value iteration step. This is, by itself, a heavy burden for a DP algorithm and 
is especially a major problem when dealing with problems with continuous state-spaces, 
such as the ones of interest to us in this study. Such problems require a preprocessing 
which quantizes their states into a finite state space in order for DP methods be applicable. 
The density of this finite space is usually proportional to the accuracy of the approximate 
representation. This means that for accurate results by DP, more and more states should be 
augmented, which in tum may load the solution algorithm with unacceptably many com-
putations. 
Taking into account that the dimension of the state space is a logarithmic function 
of the number of states, linear growth in the dimension gives rise to exponential increase 
in the space requirements of any DP algorithm. This effect has been first named by Bell-
man as the curse of dimensionality. It constitutes the most serious obstacle for application 
DP methods; because many real-life decision problems can only be modeled on larger di-
mensional state-spaces than any available processor can accommodate to perform a DP 
solution in reasonable amount of time. It should be noted that the drastic improvement 
on processor speeds in the last few decades made accommodating many problems within 
this framework possible (Powell, 2005). Although the borders of the application field of 
DP algorithms seem to be drawn by the technology from this point of view, a certain tech-
nological level that would infallibly overcome the curse of dimensionality can never be 
gIVen. 
The second major problem of DP methods is that the process must be modeled by 
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exact state transition probabilities. That is knowing the process model exactly is essential 
to carry out a conventional DP solution. With any amount of inaccuracy in represent-
ing these parameters, one can no longer guarantee the optimality of the resulting policy. 
Needless to say, the lack of information on some or all of these parameters is absolutely 
intolerable since the algorithm requires their explicit values in the value iteration step. As 
a result, conventional DP methods are certainly classified as model-based methods, which 
contradict with the point of view to the medical decision problems in this study. 
These two issues, common to all DP solutions, can only be resolved by replacing 
two fundamental sub-procedures, namely value and policy iteration, by their approximate 
versions. As in any approximation, the benefits of this substitution corne at the expense of 
settling with a sub-optimal policy instead of the exact solution 7r*, which would really be 
ensured by the conventional DP solution. 
Approximate Dynamic Programming 
The role of approximate DP methods in solving MDP is interpreted as twofold in 
this study, as previously mentioned and described in the remainder of this chapter. There-
fore the treatment of ADP in this study is broader than the views that consider ADP solely 
as a method of parameterizing the DP table to overcome the scaling problem. Though 
addressed rigorously in the following sections, such a parameterization constitutes a sec-
ondary goal for us that will even be disregarded in some of the demonstrations on the 
following chapters. 
Instead, the focus here is mostly on addressing the problem of unknown (or partially 
known) transition probabilities here. This is viewed as the primary shortcoming of conven-
tional DP methods, because obtaining the patient behavior (i.e. the process model) in a 
medical treatment may be too costly from many aspects. The medical decision maker thus 
faces the difficulty of extracting the process model (i.e. how the patient responds to medi-
cal decisions) simultaneously with achieving the therapeutic goal. He/she does not usually 
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have a patient model to begin the control directly, and without a model conventional DP 
methods are simply inapplicable. This is a typical chicken and egg problem. 
As will be shown shortly, a solution to this dilemma brings another form of approx-
imation scheme into the big picture of staged decision making. It deserves an analysis still 
under the ADP topic, although this new approximator serves for another purpose than the 
standard view to ADP suggests. 
Coping with Model Uncertainty within MDP 
Making decisions on a MC with unknown transition probabilities and rewards is 
troublesome but common matter in critical tasks, including medical treatment processes. 
Moreover, in many of these instances, one has no access to the process (c.f. the black box 
phenomenon), which renders the simulation as the only method to gain information on the 
dynamics. In particular, the system must be probed by a set of inputs at certain states and 
the parameters of the dynamics must be determined based on the observed outcomes from 
the black box, i.e. state transitions. The goal here is to explore the system. 
Reaching the optimal policy, on the other hand, is a serious control task, and a con-
stant improvement in the state values, as guaranteed by the conventional DP algorithms, 
must be exploited to solve the problem. Since the two goals conflict in general, a standard 
approach in handling unknown (or partially known) processes is to isolate exploration from 
exploitation (Barto et aI., 1995).4 The former, also called the modeling process, is inde-
pendent of the upcoming control efforts, and the sole objective is to represent the dynamics 
as accurate as possible. The latter comes in effect strictly after the modeling is over (or 
suspended) and during its operation, the obtained model on the preceding step is assumed 
to be perfectly accurate (i.e. certainty equivalence principle). 
In some most critical instances, however, there is no time to perform exploration and 
4This trade-off has deep roots in control theory. It is a fundamental problem of adaptive control (Astrom 
and Wittenmark, 1989; Kumar, 1985). 
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exploitation separately, thus it is further necessary to combine the two (usually conflicting) 
efforts. Again, most medical decisions are subject to this requirement, due to limitations 
on treatment time. 
Simulative approximate dynamic programming methods combine simulative mod-
eling (i.e. learning the model) with the continuous tendency to encountering advantageous 
states towards the objective (i.e. MDP solution). These methods include various forms of 
reinforcement learning (Sutton, 1988) that will shelter also the methods utilized/developed 
in the sequel. The unique feature utilized in these methods is their ability to maintain both 
goals simultaneously and reasonably accurately. 
The viewpoint adopted in this study is augmented by computational intelligence 
components. The focus is specifically on the design and analysis of learning systems that 
maintain a particular DP method to solve such a decision problem, given only sequences of 
data generated by the dynamic process. Since the dynamical form governing the process is 
disregarded in this setting, the objective could be classified as a model.Jree control task. 
The basic strategy common to the methods of interest here is to make use of the 
information gain obtained by the state transition i ----+ j and the corresponding reward 
9 (i, n( i), j) in updating the values in the DP table. In fact, such an observation contains a 
novelty as an aid in coping with the two unknowns, i.e. the value J( i) and the transition 
probability Pij' 
Method of Temporal Differences 
Being an alternative to the value iteration step of conventional DP algorithms, Tem-
poral Difference (TD) methods, parameterized by A E [0, 1] is an iterative way to calculate 
the state values under a specified policy in effect (Sutton, 1988). 
TD iterations are applied on a sample trajectory generated by the actual process, 
whose transition probabilities are typically unknown. TD(A) is an episodic (approximate) 
value iteration process in the sense that the TD iteration is repeated within a loop, for each 
23 
state transition observed in the sample trajectory. When the sample trajectory is finished, 
the stage is left for a policy iteration procedure, where the policy in effect is improved by 
examining the resulting value function, which was prepared by the last TD iteration step. 
The learning proceeds with a new trajectory generated by the new policy. 
A single iteration ofTD performs partial correction on the current state values based 
on a comparison between the immediate reward observed and the values of the last and the 
current state. Note that these three quantities are strictly linked to each other by (6). 
In the basic case of A = 0, a backup toward the correction is performed by 
where 0['] is a positive learning rate sequence. Using a well-known result from the stochas-
tic approximation theory (Poljak and Tsypkin, 1973), o[k] is selected in this iteration (and 
in almost all variants of TD) as a diminishing step-size satistying limk-->oo o[k] -t ° and 
2::;::00[k] < 00. 
For A > 0, the immediate correction is propagated towards the values of future 
states, which will be examined later in the sample trajectory: 
1-1 
.r(Xk) +- J7r(Xk) + o[k] L Ak- m (g(Xm, 7f(Xm) , Xm+l) + a.r(xm+d - J(Xm)) , (13) 
m=k 
where 1 is the episode length. The rationale behind introducing this propagation is that the 
values of the future states will effective in the current state's value due to the basic relation 
(6). 
Validated by the convergence results (Sutton, 1988; Jaakkola et al., 1994), tabular 
TD methods constitute one of the most efficient ways of learning from trajectories. On the 
other hand, TD is a stochastic process that is biased on the selected samples, so the method 
may not be fast enough in deciding on the optimal policy to be applied in many critical 
applications. 
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Value Function Approximation 
For a parametric approximator ¢(., r) utilized to represent the state values, TD()') 
iteration can be converted to the update rule of the parameter vector r as 
/-1 
r[k + 1] = r[k] + 6[k]V'¢(Xb r[k]) L ).k-m (g(Xb 7r(x~;), Xk+l) 
m=O 
which is actually an incremental gradient update of r based upon the observation of 
g(;r;b 7r(Xk), xk+d (Bertsekas and Tsitsiklis, 1996). 
The convergence of the last iteration has not been established for all approximation 
models, i.e. for all forms of ¢( ., r). In fact, it has been shown in (Tsitsiklis and van Roy, 
1997) that it diverges for a particular closed-form nonlinear model. Available constructive 
results (Dayan, 1992; Bradtke and Barto, 1996; de Farias and van Roy, 2000; Boyan, 2002; 
Bertsekas et al., 2004) on the performance of TD with value function approximation are 
currently limited to the basic case of linear approximation of J ( . ). 
The primary benefit of value function approximation is the reduced computational 
demand of maintaining a parameter set compared to the tabular TD. In fact, parametric ap-
proximation appears to be the unique opportunity to cope with the curse of dimensionality, 
the serious thread on applicability of tabular DP methods, as mentioned above. 
Although the nature of TD does not allow for eliminating completely the adaptive 
nature of the procedure on the presented trajectory (as this data constitutes the sole informa-
tion that needs to be presented sequentially to the method), it is indeed possible to reduce 
the expected time for the procedure to finalize the parameter updates on the approximation 
scheme (Bertsekas et al., 2004). Unlike the tabular methods, several state values are af-
fected by the parameter update performed based on a single state transition. This should be 
viewed as a side-benefit of dynamically approximating the value function. 
Value function approximation is the most popular way of incorporating connection-
ist schemes into this learning task. An approximation scheme employing an RBF network 
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is suggested in the Chapter IV on a case study. 
Policy Approximation 
Another point where parametric approximation could aid ADP methods is the pol-
icy representation. In the original ADP setting, the policy is maintained in the form of 
a explicit lookup table relating states to the control actions. It should be noted that there 
are other approaches which take the concept of policy in different ways, such as probability 
distribution of actions given each state (Sutton and Barto, 1998). However, in any case, this 
table identifies an algebraic relation, which could really be implemented as an input-output 
relation of a parametric approximator. 
Although such an approximator has nothing to do with the curse of dimensionality, 
there are still two important reasons to employ it: First, as in the case of value function 
approximation, the computational burden of updating a tabular policy (by policy iteration 
methods) grows exponentially with the dimension and cardinality of the state space. Sec-
ond, the discrete nature of MDP results in a policy which is valid only on discrete points 
(states), and there may be a practical necessity to extend the policy to a continuum sampled 
by these points. In the latter case, the role of the connectionist tool integrated in the learn-
ing process goes beyond just approximation and turns out to be an interpolator of a general 
continuous control law as illustrated in Figure 2. 
RBF networks have been proven to be effective tools for generalizing the control 
law (Sanner and Slotine, 1992). An RBF-based policy approximator is proposed also in 
Chapter IV. 
Control-Oriented Variants 
DP table is a novel and very useful tool, which is processed based on observations 
of the actual system behavior and then used indirectly to develop a control strategy. As 
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Discrete Policy 





Figure 2. Policy interpolation. 
mentioned in the MDP definition, correct evaluation of states according to (1) is equivalent 
to solving the problem. Having obtained the values of the states, it is straightforward to pick 
actions that yield the most advantageous states, constructing an optimal policy. However, 
even after correct evaluation, the trivial maximization of the state values over the control 
actions may be costly, especially when there are too many alternative actions to take. 
At the cost of populating the DP table, it is possible to simplify this final maximiza-
tion stage by evaluating each state-action pair, instead of leaving the effect of actions on 
the state values implicit in the state values, as done in (1). With this extension the DP table 
becomes a 2D array with entries pointing to the value of state-action pairs: 
Q(s,a) ~ E [f(lg(Xk,ak,Xk+l) Xo = s,ao = a]. 
k=O 
(15) 
The Q-values are then updated according to generalized versions of TD methods, 
called Q-Iearning methods. In particular, the generalized version of TD(A) (c.f. (5)) to 
maintain the new DP table is given by 
I-I 
Q(Sk' ak) +- Q(Sk, ak)+5[k] L Ak-m (g(Sm' am, Sm+l) + aQ(Sm+l' am+l) - Q(Sm, am)), 
m=k (16) 
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l being the episode length. The convergence of this iteration to real Q-values is established 
in (Watkins and Dayan, 1992; Tsitsiklis, 1994) under mild statistical assumptions. 
Using Q-values instead of J's trivializes the policy iteration step as the best action 
for a state s is the index of the maximum element of the row indexed by s, which is evident 
in the Q-table. Since control actions are addressed explicitly in this formulation, Q value 
representation is in general preferable when dealing with control problems. To cope with 
medical decision problems, which are considered as control problems in this study, this 
particular view is adopted and the considered ADP methods are picked among Q-learning 
methods and their variations. The discussion made in the preceding section on approxima-
tion is still valid in this new learning scheme. 
A critical issue in the choice of the suitable ADP tool is to decide whether to learn 
on-policy or off-policy. Off-policy methods enable learning by observing the effects of a 
policy other than the one processed, so that probing the process (i.e. the patient in medical 
problems) with inadequate policies may be avoided. This feature makes off-policy methods 
appropriate tools for medical applications considered in this study. On the other hand, on-
policy methods are mathematically tractable and, hence, attract the majority of the research 
efforts in AD P. 
As a final note, the TD and Q-Iearning iterations presented above constitute a gen-
eral framework of many simulation-based control methods and is dependent only on the 
observed state transition and the resulting reward. Therefore, they do not actually point to 
a specific type of the learning method in the above terms. What categorizes a simulative 
ADP method as an on- or off-policy is the source of the policy being applied to generate 
sample trajectory, which is then processed by TD or Q-leaming iterations. 
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CHAPTER III 
ANEMIA MANAGEMENT PROBLEM 
In this chapter, the problem of anemia management in patients with End-Stage Re-
nal Disease (ESRD) is introduced as the test problem on which the methods of this study 
will be demonstrated. 
Anemia due to End Stage Renal Disease (ESRD) is a common chronic condition 
in patients receiving hemodialysis (Eschbach and Adamson, 1985). The reason is known 
as the insufficiency of a hormone called erythropoietin (EPO), which stimulates the pro-
duction of red blood cells (erythropoiesis). In fact, the hemoglobin (HGB) is the building 
block of these cells and its derivation in blood known to be correlated with that of EPO. 
The preferred treatment of renal anemia consists of external administration of recombinant 
human erythropoietin (rHuEPO, or EPO). Treatment process aims at maintaining the HgB 
level between 11 and 12 gldL. This problem is formulated in the sequel as a MDP with 
unknown transition probabilities. 
Individualization of Chronic Pharmacotherapy 
Drug administration in chronic conditions is a recurrent trial and error process. Typ-
ically, a physician selects an initial drug dose based on a standard reference and observes 
the patient for specific response and/or side effects. Following the observed state of the 
patient, the dose is adjusted to improve the response and/or to minimize dangerous side 
effects. The adjustment continues until a desired response is achieved. Therefore, the 
physician can be viewed as an agent performing goal-oriented learning. 
Oftentimes, the relationship between the drug dose and the patient's response is 
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complex. Practitioners attempt to use protocols and algorithms to simplify this relationship. 
However, protocols and algorithms are developed from average responses to treatment in 
populations of patients. Individualization of drug dosing is complicated by the patient's 
response to the drug and to other concurrent medications. 
The application of DP methods in pharmacotherapy has been advocated by Bell-
man (Bellman, 1983). A pioneering example for drug delivery optimization can be found 
in (Buell et aI., 1970). Other examples include the works of Hu et aI. (Hu et aI., I 994b; Hu 
et aI., I 994a). Very recently, Shaeffer et al. (Schaeffer et aI., 2004) provided a review of 
modeling medical treatments using MDP. Moore et aI. (Moore et aI., 2004) demonstrated 
a successful application of the Q-Iearning algorithm to closed-loop control of patient seda-
tion in an intensive care unit. 
Anemia is an almost universal sequel in an ESRD patient. Until the introduction 
of recombinant human EPa, ESRD patients faced severe cardiovascular risk factors due 
to multiple transfusions. However, the use of EPa creates additional challenges to the 
physician. The National Kidney Foundation's Dialysis Outcomes Quality Initiative recom-
mends maintaining HGB levels within a narrow range of 11 - 12 gldL. To achieve this, 
protocol-based strategies exist for EPO administration. 
Based on the population response, these strategies adjust the dose amount or the 
dosing frequency based on the HGB level. The dosing of EPO is labor intensive and re-
quires trained personnel to assess monthly HGB and iron levels and to make adjustments 
or assessments every two or four weeks. Having computational tools support the medical 
personnel in this difficult task would be a major step forward. 
Problem Statement 
The problem of anemia management for a given patient is a typical staged decision 
problem under uncertainty. The quantity to be kept under control is the HGB, whereas the 
control input is the amount of EPa administered by the physician. The iron stores in the 
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patient, determined by Transferrin Saturation (TSAT), have an impact on the process of 
red blood cell creation and are considered as a state component together with HGB. In this 
setting, the patient is viewed as a discrete-time dynamic system with the state space 1i x S, 
where 1i and S are sets of valid HGB and TSAT levels, respectively. The control space, 
i.e. the set of valid EPO amounts, is denoted by E. As the measurements are performed 
monthly, the time index k in the state representation denotes the months. 
Patient Model 
In the classical pharmacological framework, a patient's response is analyzed using a 
PKlPD compartment model containing a set of differential equations. In the case of the red 
blood cell production, called erythropoiesis, regular measurement of EPO concentration 
would be required to acquire all the information necessary to build a PKlPD model. Due 
to the high cost of this procedure, alternative modeling methods, such as Artificial Neural 
Networks (Zurada, 1992), become a feasible option. In (Gaweda et aI., 2003), a population-
based neural network was proposed for dose-response modeling in anemia management. 
For the purpose resembling a patient in generating simulated trajectories, a sub-
population approach (Brier et aI., 2006) is used to make up a patient. The underlying 
principle for this approach is the existence of several characteristic response groups within 
a patient population. Each one of these groups is assumed to bear a unique dose-response 
relationship. Using fuzzy rules, a patient's response is first classified and subsequently 
a one-step-ahead prediction of HGB level is obtained using the following second-order 
model: 
xdk + 1] Bla[k - 1] + B2a[k] + B3a[k + 1] + 
B4XI [k - 1] + B5XI [k] + B6X2 [k] + Bo (17) 
where a is the control input (EPO), Xl is the HGB, and :1;2 is the TSAr. The response is 
classified based on the six month average levels of HGB, TSAT, and EPO. The proposed 
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approach can be conveniently implemented using Takagi-Sugeno (TS) fuzzy model (Takagi 
and Sugeno, 1985). 
Records of 186 patients at the Division of Nephrology, University of Louisville, 
were used in this study to perform data-driven estimation of the TS model. The data were 
randomly divided into equally sized estimation (training) and evaluation (testing) sets, con-
taining data of 93 patients each. For consistency, a total of 100 model estimations were 
performed using different patient selections for estimation and evaluation. Eventually, the 
following three-rule TS model was obtained: 
R 1 : If (avg EP06m, target HGB6m , norm TSAT6m) 
Then HGB[k + 1] = 8 1 ( 
R 2 : If (avg EP06m, target HGB6m , low TSAT6m) 
Then HGB[k + 1] = 8 2 ( 
R3: If (high EP06m, low HGB6m, low TSAT6m) 
Then HGB[k + 1] = 83 ( 
In these rules, the subscript 6m denotes the six month average of the corresponding quan-
tity, 8 i are the parameter vectors of the predictive model (17), and (is the regressor vector: 
( = [EPO[k - 1], EPO[k], EPO[k + 1], 
HGB[k - 1], HGB[k], TSAT[k], 1] 
Two rules (Rl' R2) specifY the HGB response for normal responders, i.e. the pa-
tients who achieve target HGB levels upon administration of average EPO amount (ca. 
12, 000 Units per week). These two rules cover normal responders with low and normal 
TSAT, respectively. The third rule (R3) specifies the HGB response function for a group of 
patient, called poor responders. These are patients who receive high amounts of EPO yet 
their HGB level stays low. The reason for using fuzzy sets to represent the response groups 
is due to the fact that patients in real life exhibit features typical for both groups to a certain 
degree. In other words, only very few patients can be classified strictly as a normal or poor 
responder. 
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The state variable X2 is assumed to be a random variable with normal distribution 
around the mean :1:2 and variance 17fSAT' The random variation of TSAT emulates the 
uncertainty in the process dynamics. The main control objective is to drive the HGB level 
to and maintain within the target range 11 - 12 gldL. For simplicity, it is assumed that 
maintaining HGB within target range is equivalent to keeping it as close as possible to the 
median, i.e. 11.5 g/dL. 
The author would like to emphasize at this point that the sole purpose of the pa-
tient model specified above is to generate realistic sequences of trajectory. In the learning 
scheme described below, the qualitative properties of this model are never taken into ac-
count by the learning system, which actually assumes that it has access to a real patient 
from its own perspective. 
MDP Setting 
The state space ofthe considered MDP is first reduced to 28 representative states by 
quantizing the HGB and TSAT intervals with medians fixed at 1i = {5, 10, 11, 11.5, 12.33, 
13, 15} and S = {10, 25, 40, 70}. The admissible set of discrete actions for each state is 
defined as £ = {O, 5,10, ... , 60}. There is a number of alternatives on the choice of the 
reward function as defined next. 
Having decided on the state and the action spaces, the second step in the formulation 
stage is to reflect the control objective, i.e. stabilization of Xl at 11.5. The designer is 
absolutely free in choosing any reward formulation as long as it is consistent with the 
specified goal. This study considers two reward functions associated to the state transition 
x[k] ~ x[k + 1]. 
The first one is chosen merely as the negative of absolute difference in the first state 
variable from the target level: 
gl (x[k], x[k + 1]) = -Ixdk + 1]- 11.51· (18) 
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The second reward formulation is a finite-valued function defined by 
-1 , 11.5 ~ xdk] > xdk + 1] 
V xdk + 1] > xdk] ~ 11.5 
0.5 , xdk + 1] > 11.5> xdk] 
V xdk] > 11.5 > .Tdk + 1] 
1 , xdk + 1] = 11.5 
o otherwise 
(19) 
Although the general ADP framework permits, these choices does not include the action 
value ark] as a parameter of the reward.s 
The task of drug dosing as an MDM is then posed as follows: For all possible initial 
conditions x[O] E 1t x S, determine the best control (action) a[O] such that the expected 
cumulative discounted reward 
Q (xIOI, ala]) ~ E [~'i 9 (xlk], xlk + 1]) alOI] (20) 
is maximized, where 0 < a < 1 is the discount factor. 
50mitting the drug dose from reward formulation implies that the resulting learning mechanism will not 




LEARNING THE DOSING POLICY 
Reinforcement Learning (RL) is a computational framework under ADP that mim-
ics the goal-oriented knowledge and skill acquisition in humans and animals. Within this 
framework, an agent interacts with its environment by performing actions and observing 
the states. Based on the state transitions, each action is rewarded or penalized, conveying a 
critic to the agent on the immediate benefit of its preceding decision. Approaching the drug 
delivery problem from this point of view, the physician can be viewed as the agent, drug 
dose - as the action, patient - as the environment, and patient's response - as the state. Sev-
eral authors have advocated the use of techniques underlying the RL to medical decision 
making (Bellman, 1983), (Hu et aI., 1994b), (Hu et aI., 1994a) over the years. However, 
applications of RL to drug administration have surfaced in the literature only very recently 
(Moore et aI., 2004). 
This chapter presents two conventional RL applied on the drug-dosing problem 
in order to extract the optimal dosing policy for individuals without any specified dose-
response model. In the first approach, beginning with a common-sense policy, the patient 
is simulated along episodes, each demonstrating the policy in effect on the unknown patient 
model. The current policy is improved by using the gained experience at the end of each 
simulation episode. This is a training-oriented approach which emphasizes exploration. 
The second approach presented here is an application of the conventional Q-Ieaming strat-
egy (Watkins and Dayan, ] 992) on anemia management, which explores and controls con-
currently. Here, the policy improvements occur at each state transition, so the policy is 
continuously changing. Therefore, there is no particular policy in effect that is being fully 
demonstrated on the patient. It is shown that, when there is a time constraint on the treat-
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ment process, which is naturally the case in clinical practice, the latter method performs 
as well as the Anemia Management Protocol, the standard dosing procedure of Kidney 
Diseases Program, University of Louisville. 
Episodic On-Policy Learning of Dosing Policy 
The first attack toward the problem has adopted episodic and on-policy interpreta-
tion of the drug-dosing process, where a learning episode includes a trajectory simulated 
with a random initial state and by using a particular policy. Here gaining experience on 
the model (by examining the state transitions) and improving the policy (by TD iterations) 
are separate and sequential subtasks in a loop. In particular, the SARSA(A) algorithm, an 
episodic on-policy ADP process, is employed here to develop a drug dosing policy for an 
individual patient. In this setting, the learning occurs by reflecting the experience gained 
within an episode to improve the policy in effect. Such a learning scheme offers a better 
monitoring of the improvement in policy along the proposed approach. 
SARSA Algorithm 
The learning progresses along the episode by evaluating each transition observed 
within the episode, the incurred immediate reward, and then by correcting the Q values of 
these transitions. In particular, it can be shown that the quantity 
6[k] = gl(x[k], x[k + 1]) + ,Q(x[k + 1], ark + 1]) - Q(x[k], ark]) (21) 
associated to the state transition x[k] ----> x[k + 1] due to the action ark] is a correction on 
the estimate Q(x[k], ark]) of the state/action pair (x[k], ark]). For each transition x[k]-t 
x[k + 1] encountered in an episode due to ark], the SARSA(A) algorithm performs the 
update 
Q(x[k], ark]) ~ Q(x[k], ark]) + v6(1 + e(x[k], ark])), (22) 
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where v is a sufficiently smallieaming rate and e(x[k], ark]) ;::: 0 denotes the eligibility of 
the state/action pair (x[k], ark]) in this correction. After this correction, before proceeding 
with the next transition, eligibility of the current state/action pair is first updated as 
e(x[k], ark]) ~ 1 + e(x[k], ark]) (23) 
and then the entire e table is iterated as 
e ~ v)..e, (24) 
where)" E [0,1] is a parameter of the algorithm (c.f. (13)). When).. is small the state/action 
pairs looses rapidly their eligibilities to update the Q entries. So the frequency of encoun-
tering a particular state/action pair in the trajectory becomes a less important effect in the 
update of the associated Q entry. For).. = 1, all encountered state/action pairs are treated 
equi-eligible in the update of Q table. Note that the introduction of e provides an efficient 
implementation of the summation appearing in the original temporal difference definition 
(13). 
After the Q and e updates for each state transition observed in the sample trajectory, 
the final step performed by the algorithm to complete the episode is the update ofthe policy 
based on the resulting Q table: 
p (x) = arg max Q (x, a) . 
aE£ 
(25) 
This particular policy determined merely as the maximum element of Q is called the greedy 
policy. 
In order to apply SARSA()") on the drug dosing problem, the initial trajectory (of 
the first episode) oflength 24 is generated using the linear model (17), where p is computed 
using the first six measurements from the considered patient. The corresponding reward se-
quence is then obtained by evaluating the reward function for each state transition observed 
in the generated trajectory. Note that there are 28 states and 13 possible actions for each 






















Figure 3. Proposed episodic anemia management scheme employing SARSA. 
For diminishing learning constant v and A E [0, 1], the iteration on the policy per-
formed at the end of the episodes based on the generated Q-table converges to an optimal 
policy, where the algorithm terminates, provided that all state/action pairs are visited fre-
quently enough (Sutton and Barto, 1998). 
The block diagram of the learning scheme proposed in this section is illustrated in 
Figure 3. 
Approximating Q-table using RBF Network 
Storing and updating the values of all possible state/action pairs explicitly in the 
Q-table necessitate exponentially larger amounts of memory and computation power as the 
cardinality of the state space expands. In such cases, a compact parametric representation 
of the Q values in the drug dosing problem turns out to be essential. Note that, the required 
approximation would not be in the traditional fonn of interpolating a finite set of static 
data, but rather constitute a representation that adapts itself incrementally to the updates 
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performed by the ADP procedure upon each state transition. 
Approximating the dynamic programming table using artificial neural networks has 
been proven to be an effective way of handling large decision making problems (Bertsekas 
and Tsitsiklis, 1996). Although it is computationally feasible to maintain explicitly the Q 
array in this problem setting with 364 entries in the setting above, in order to shed light onto 
the expanded versions of the considered problem, a connectionist approximation scheme is 
incorporated with the original SARSA method. 
An RBF-based approximation scheme is considered here, because such algebraic 
networks enable localized parameterizations (Park and Sandberg, 1991) in the sense that 
each RBF node in the network and its parameters are related to the approximation perfor-
mance on a particular sub-region of the input space only. This would be a useful feature in 
updating only the Q values of the observed state/action pairs along the SARSA iteration, 
without modifYing the values of irrelevant pairs. 
In the approximation scheme proposed here, the finite state space augmented by the 
action space (1t x S x £) is first partitioned into'" nonempty partitions and then the rep-
resentative state for each sub-region is determined. Such a partitioning could be achieved 
effectively by a clustering procedure, such as the k-means algorithm (Bishop, 1995). Then 
each of these representative states is assigned as the center of a Gaussian RBF node. The 
widths of the RBF nodes are fixed. The considered RBF network here has 3 inputs, namely 
Xl [k], x2[k], and ark]. The output layer consists of a single linear unit with the real weight 
vector w. The algebraic function implemented by the network is given by 
<p (z) = w T 
exp (_IICl -Zll~) 2ai 
( IICf-Zii§) exp - 2 2 a f 
(26) 
where Ci and af are the center and the width parameter of the i-th RBF node, respectively. 
The output weights are adjusted in compliance with the original Q-update mecha-
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nism (22): 
w* +-- w* + v6(1 + e(x[k], ark])) (27) 
where w* is the output weight parameter from the RBF node whose center is closest to the 
observed state/action pair (x[k], ark]). 
Experimental Results 
To perform an experimental evaluation of the proposed method, an artificial group 
of200 patients was used. Out of this group, the first 100 were typical for normal responders, 
while the remaining 100 were typical for poor responders. For each individual patient, a 
trajectory of EPO, TSAT, and HOB was generated over 6 months. 
Experiment 1 A normal responder is considered in this experiment. After setting the Q-
table and the eligibility matrix to zero and picking a random initial policy, a trajectory of 
length 30 was generated using the TS model described in Section IILC. The variance of 
TSAT was O"§AT = 100. It is important to note that there is no indication about the patient's 
membership in the response group other than the first six entries ofEPO, TSAT, and HOB, 
so the patient model is absolutely unknown to the learning system. 
The SARSA(A) procedure was then applied as described above with A = 0.1, "Y = 
0.9, and v = 0.99. Following each Q-update along the trajectory, v was multiplied by 0.9. 
The state variable Xl settled within the 5% band of the target value 11.5 after 5 episodes. 
The Euclidean norm of the difference between the actual HOB level and the target value 
11.5 for each episode are shown Figure 4. This figure also presents the variability of HOB 
level, expressed in terms of standard deviation. 
The resulting policy was finally on a normal responder. The amounts of EPO ap-
plied according to the policy and the resulting HOB level are shown in Figure 5. The 
effectiveness of the policy obtained by SARSA iteration is evident. 
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Figure 4. Variation ofHGB level from the target 11.5 g/dL (top) and variability ofHGB 
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Figure 5. The sequence of administered EPO doses (top) and the resulting HGB trajectory 






















CXl .. ~ (!) 
:::c "1"1" --.' 
0.5 
0 
0 50 100 150 200 
episodes 
Figure 6. Variation of HOB level from the target 11.5 gldL (top) and variability of HOB 
level (bottom) on simulated trajectories of a poor responder after 200 episodes of SARSA 
procedure. 
adequately change in response to the EPO applied. Such a patient is classified as a poor 
responder. Experiment 1 was repeated for this patient with the same (4SAT' r, v, and A 
values. The difference between the actual HOB level and the target value over 200 episodes 
and the HOB variability are shown in Figure 6. 
The resulting policy was tested on a poor responder in a similar vein as it was done 
for the normal responder. The EPO doses administered to the patient following the policy 
and the corresponding HOB levels are shown in Figure 7. 
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Figure 7. The sequence of administered EPO doses (top) and the resulting HOB trajectory 
(bottom) on the poor responder policy. 
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Table 1 
Simulation Statistics of SARSA Learning 
Responders HGB level HGB EPO dose EPO 
(g/dL) variability (1,000 U) variability 
Normal 11.45 ± 0.36 0.44 ± 0.12 14.7 ± 4.5 7.6 ± 2.0 
Poor 11.42 ± 0.66 0.91 ± 0.27 43.6 ± 5.8 7.5 ± 6.5 
HGB level to the target range and to fix it there was expected to be higher than that of a 
normal responder. This phenomenon can be verified from Figures 5 and 7 by comparing 
the administered EPO amounts. 
The results of the two experiments given above show that the original SARSA(A) 
algorithm can be used to adjust the drug dose in both types of responders. 
Experiment 3 Having established the ability of the proposed method to discover individ-
ual EPO dosing policies, a series 200 simulations over the whole population of artificially 
generated normal and poor responders was performed, where the same SARSA parameters 
as in Experiments 1 and 2 were used. The results of this simulation are summarized in Ta-
ble 1. The HGB level and variability (defined as Standard Deviation) are in gldL, whereas 
the EPO dose and variability are in 1,000 Units per week. The entries in the table are mean 
± standard deviation (computed over 100 individuals within each response group) 
The results summarized in Table 1 confirm the findings of the first two experiments. 
The mean HGB levels close to 11.5 for both groups, as well as a relatively low HGB vari-
ability show that the proposed method consistently generates adequate EPO administration 
policies for both types of responders. 
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The RBF-based approximation scheme proposed in Section lV.B.l was finally ap-
plied to parameterize the Q-table. The first entry of the RBF centers is associated with 
the HGB level (Xl) and the second one to the EPO (a). In this simulation, the TSAT state 
component was discarded, because the policy entries were mostly independent of the TSAT 
variable. The number £ ofRBF nodes was then picked as 91 and their centers were assigned 
to the HGB/EPO pairs in 1i x E. Note that neglecting TSAT value in the determination 
centers is equivalent to assigning all states with the same HGB and EPO values to the same 
point in the input space. (There are lSI = 4 such states for each HGB and EPO in this 
setting). The width parameters 0'1, ... , 0'91 have been set equal to 0.01 and initial weights 
to zero. The RBF-based SARSA algorithm was performed by replacing (22) with (27) to 
the individuals considered in Experiments 1 and 2. 
The Euclidean norm of the difference between the policies obtained by the original 
SARSA (poIQ) and its approximate version (poIRBF) at each episode is shown in Figure 8. 
This plot was generated for the normal responder and the poor responder policy exhibited 
almost identical convergence. As can be observed, the approximate version of the SARSA 
algorithm converges to a policy similar to the one obtained by the tabular algorithm. 
Off-policy Learning of Dosing Policy 
To demonstrate an off-policy learning tool on the test-bed, the control-oriented ADP 
method introduced in Section 2.C.5 is utilized, where gaining experience and improving the 
policy are considered as integrated subtasks to be achieved simultaneously. The learning 
occurs in the form of immediate improvements (i.e. Q-value updates) reflected to the policy 
due to the experience gained by observing the HGB and EPO sequences of an individual 
patient. As delineated below, the learning system is particularly responsible for calculating 
optimum actions (EPO in 1,000 Unit steps) to be taken at each representative HGB level. 
The amount of EPO to be applied is then calculated based on the actual (non-quantized) 
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Figure 8. The difference between the two policies obtained by plain SARSA and its ap-
proximated version using RBF network. 
from the finite samples produced by the learning system. 
Q-Learning System 
Unlike the MDP formulation adapted for episodic learning scheme of the preceding 
section, the patient dynamics (c.f. Section IILe) is considered as operating on a continuous 
state-space, 1t = [9, 15], S = [0,40], £ = [0,60], but the quantities presented to the 
learning system are quantized to some finite representative values denoted by it, t. The 
learning system observes the quantized current state (HGB level) Xl [k], the quantized action 
(EPO dose) o'[k], and the quantized successor state xdk + 1]. Given this information, the 
rewarding mechanism embedded in the learning system evaluates g(xdkJ, xdk + 1]) based 
on the immediate contribution of the current state transition toward the control goal. The 
finite-valued reward formula given by (19) is used in the considered learning task. The 
proposed control scheme is illustrated in Figure 9. 
The update equations in this form of Q-Iearning is the same as (21)-(24). The 
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a[k] x[k+ I] 
a[k+ I] RBF a[k] Network 
Patient xI [k+ I] 
x2[k (Fuzzy Model) 
xI [k] 
z-I 
Figure 9. Block diagram of the Q-Iearning-based decision process. 
action ark] is then related to the current quantized state Xl [k] through the algebraic policy 
p( .) : it -+ t. The learning scheme employs a slightly modified version of the greedy 
policy (25), namely E-greedy policy defined by 
A {argmaxuEE Q (x, a) , 
Pc (x) = 
an arbitrary element of £ 
Z> E (28) 
otherwise 
where Z is a random variable distributed uniformly within [0, 1], and E E [0, 1] is a param-
eter of the learning algorithm. Note that the policy updated in this way contributes to the 
exploration effort toward the optimal policy in a different way than the dynamic uncertainty 
.1:2 does. 
The fundamental difference of this learning scheme from the episodic method of 
the preceding section is that the policy update is performed immediately after the Q-table 
update. Hence, at any given time, there is no prescribed policy in effect, which makes the 
learning off-policy. 
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RBF Policy Network 
Since the resulting policy (28) obtained by the Q(,X) algorithm is valid only for the 
quantized states x E il, in order to be applicable to the considered patient model, p(.) 
needs to be generalized to the cover H by means of an interpolator. 
An RBF network with lill Gaussian RBF nodes centered at the representative states 
is proposed in this study. The actual EPO dose to be applied for a given HGB level Xl [k] is 
then determined by this policy network as 
( X![kl-Sl) exp ---u-
(29) 
( 
Xl [k1-S l1il ) 
exp - u ' 
where {Si} l~ll' are the representative states, i.e. the elements of the quantized state space 
H. 
Since the representative states are equally spaced in H, the spreads (J of the Gaus-
sian nodes can be picked as 
d 
(J = 2' 
so that the outputs of all nodes add up to approximately 1 for all points in H, where d 
is the distance between two consecutive representative HGB levels in il. This enables 
assigning valid degrees of membership to the representative levels, so that the network 
gives an acceptable EPO dose in the form of the weighted sum of the actions imposed by 
the discrete policy. In this way, the RBF network plays a critical role by implementing the 
algebraic policy in the proposed drug dosing scheme. 
Experimental Results 
To perform an experimental evaluation of the proposed method, an artificial group 
of200 patients was created. Out of this group, the first 100 were typical for normal respon-
ders, while the remaining 100 were typical for poor responders. As was done in the testing 
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of episodic learning, a trajectory of EPa, TSAT, and HGB was generated over 6 months 
for each individual patient. 
Five years of anemia management was simulated for each patient group using the 
following two methods: 
• Q-Ieaming with RBF Policy Network 
• Anemia Management Protocol (AMP) 
Anemia Management Protocol is a numerical implementation of an EPa adminis-
tration protocol which is currently used at the Division of Nephrology. This last simulation 
was performed to establish a gold standard to which the results obtained by Q-leaming can 
be compared. It must be pointed out that the AMP uses a mechanism for determination of 
EPa dose which is quite different and more involved than the one used in the Q-Ieaming 
based scheme. Furthermore, the administration strategy implemented by AMP is fixed a 
priori, as opposed to the one used in Q-Ieaming, which evolves in time. The dose selection 
procedure, as implemented in AMP, can be shortly described by the following expression: 
l!.EPO [kl = F [HGB[k - 1], HGB[k - 2], 
HGB[k - 3], EPO[k - 1ll 
This is a higher order dynamic system, as opposed to a simple algebraic policy representa-
tion in ADP. 
To apply Q-learning, the state (HGB) was quantized into 5 equally sized intervals 
with medians at: 9.5, 10.5, 11.5, 12.5, 13.5 g/dL. These four values constituted the finite 
set it explained above. The finite action set used by the learning system was set as £ = 
{O, 5, 10, ... , 60}. Due to clinical constraints, the action values in E were also rounded 
to the nearest integer.6 
61,000 EPO Units is the lowest dose increment currently used. 
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In each simulation, the treatment was started at the seventh month. The Q-table was 
initialized using a best guess method such that the most viable policy was used in the first 
step. The best guess policy used in the simulations was as follows: 
HGB (g/dL) 9.5 10.5 11.5 12.5 13.5 
EPO (1,000 U.) 60 30 15 5 0 
When a new patient comes in, they cannot be classified immediately to a response 
group. This information is obtained as the treatment progresses. Consequently, using one 
sound and common initial policy and tailoring it for the individual patient during treat-
ment is a viable solution. Thus, the same initial policy was used for both response groups. 
Furthermore, all updates to the policy entries at the extreme states 9.5 and 13.5 were in-
hibited. The motivation underlying this decision is that when HGB reaches a dangerously 
low level, the maximum EPO dose 60 is the only feasible action. On the other hand, when 
HGB level is too high, EPO should be withheld. These extreme states are undesirable and 
it is expected that the system avoids them. 
Due to the nature of the problem, the policy exploration was limited to time in-
stances when the system was visiting the target state. In other words, E is nonzero only 
when 11.0 :::; Xl :::; 12.0. In this case, the exploration probed how decreasing EPO affects 
the patient's response. Such an exploration aims at minimizing the patient exposition to the 
drug, as well as the total EPO administered. 
In the simulation involving the Q-leaming procedure, A was 0.1, the diminishing 
learning rate was 1I = 11k, the discount factor was "( = 0.9, and the exploration parameter 
was E = 0.3 when the system encountered the target states and E = 0, otherwise. The 
spreads of the RBF nodes were picked as (T = 0.5. 
Figures 10 and 11 show the progress of anemia management for a selected repre-
sentative normal responder. The top plots in each figure depict the HGB trajectory obtained 
as a result of administering EPO as shown in the plots second from the top. As an indicator 
of convergence of the Q-leaming process, the third plot from the top of Fig. 10 presents 
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Figure 10. HGB level (top), EPO dose (second from top), the magnitude ofthe Q-table up-
dates (third from the top), and policy evolution (bottom) for an individual normal responder 
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Figure 11. HGB level (top) and EPO dose (bottom) for an individual normal responder as 
performed by AMP. 
the maximum norm of the deviation in the Q-table along the treatment. The bottom plot 
in Figure 10 shows the policy evolution. Each curve in the policy plot represents an ac-
tion for the corresponding state as marked to the right of the plot. By analyzing the HGB 
trajectories, it can be concluded that Q-Ieaming achieves the therapeutic goal. 
This observation is also confirmed in Tables 2 and 3, where the statistics ofthe sim-
ulation are presented in terms of the mean value and the 95% confidence interval calculated 
over 100 patients for the following outcome measures: 
• mean HGB level over the treatment period, 
• standard deviation ofHGB over the treatment period, 
• total EPO used during the treatment. 
The simulation statistics presented in these tables for normal responders show no significant 
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Figure 12. HOB level (top), EPO dose (second from top), the magnitude of the Q-table 
updates (third from the top), and policy evolution (bottom) for an individual poor responder 
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Figure 13. HGB level (top) and EPO dose (middle) for an individual poor responder as 
performed by AMP. 
Figures 12 to 13 show the progress of anemia management for a selected represen-
tative poor responder. The most profound difference between the HOB trajectory of a poor 
responder and that of a normal one is the time to get to the target range. It takes an average 
of 2 months for the HGB to find the target range for a normal responder. For the poor 
responder, this period takes from 8 to 18 months. It can be observed that the Q-learning 
takes longer to get the HGB level of a poor responder to the target range, compared to the 
AMP. This phenomenon can be attributed to the policy update occurring at the beginning 
of the therapy. Evidently, the initial action for HOB = 10.5, namely 30, 000 Units of EPa 
administration, is not aggressive enough for a poor responder and causes a drop in HGB. 
As mentioned above, HOB below target is an undesired behavior, thus such an action re-
ceives a relatively low reward (or punishment) so that a different action is selected in the 
next step, based on the Q-table. This process contributes to increasing the time required to 
reach the target HOB range. Consequently, the AMP, as a prescribed policy, works faster 
for a poor responder, than Q-Iearning, which learns the policy on-the-fly. Nevertheless, 
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Table 2 






HGB Level (11.12, 12.04) (10.76,11.55) 
HGB 0.29 0.74 
Variability (0.15,0.42) (0.52,0.95) 
Total EPO 589.29 1145.25 
(1,000 U) (344.56,834.02) (926.61,1363.88) 
statistics presented in Tables 2 and 3 for poor responders show that the policy obtained by 
Q-Ieaming and AMP achieve a comparable outcome. 
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Table 3 





HGB Level (11.56,11.78) (11.35,11.67) 
HGB 0.32 0.67 
Variability (0.22,0.41) (0.49,0.84) 
Total EPa 610.57 1075.39 
(1,000 U) (356.91,864.23) (942.50, 1208.28) 
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CHAPTER V 
GOAL-ORIENTED LEARNING DRIVEN BY CLINICAL KNOWLEDGE 
This chapter presents an extension to the Q-Iearning method demonstrated in the 
preceding chapter. An alternative Q-value update scheme is proposed here that is based 
on a critical prior knowledge about the dose-response characteristic: For all patients, it is 
known that the dose-response curve of HGB vs. EPO is monotonically non-increasing. 
For example, if a patient's response is evaluated as insufficient for a particular dose at 
a particular state, then the physician knows that the optimal dose for that state should 
definitely be higher than the administered one. Consequently, there is no need to explore 
the benefit of lower doses for that state in future decision stages of treatment. 
The conventional Q-Ieaming algorithm does not possess any mechanism to utilize 
this type of prior information in learning. Hence, this learning method may lead to sub-
optimal HGB levels for some patient populations (especially those with decreased EPO-
response). Therefore, an additional mechanism is suggested here to be incorporated in the 
original Q-Iearning algorithm so that the information about monotonically increasing char-
acter of the HGB vs. EPO curve can be incorporated in the update procedure. It is shown 
in the sequel that such a modification will make the EPO dosing faster and, thus, more 
efficient. 
This study suggests a novel mechanism to perform group updates in Q-table, which 
is now considered as a time-invariant but a nonlinear function of the state/action pair en-
countered. The group of state/action pairs to be updated for each state transition is defined 
a priori, with prior knowledge about the problem. Such an aid to the learning process is 
categorized as an advice in reinforcement learning theory. 
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Use of Advice in Reinforcement Learning 
The idea of propagating the experience gained by the most recently-encountered 
state/action pair toward the value updates of other pairs is utilized in the general Q('x} algo-
rithm (Watkins and Dayan, 1 992). The eligibility trace (Sutton and Barto, 1998) constitutes 
an efficient mechanism to implement this learning scheme. Eligibility of a state/action pair 
e(x, a) has been defined below eq. (24) as a temporal variable, which attains its maximum 
of 1 as soon as (x, a) is encountered in the simulation and vanishes geometrically by the 
predefined constant rate ,X E [0,1] along further observations. The value updates of all 
state/action pairs are then performed in parallel upon each information gain, but weighted 
by their corresponding eligibility. 
Eligibility trace performs specific time-varying abstraction temporal difference it-
eration. It has an accelerating effect on the convergence of the Q-table, since it gives rise 
to the update of multiple entries upon the observation of a single state transition. Given the 
fact that many real-life problems come indeed with a set of prior information or hints about 
their solution, there may be other forms of abstractions as well, and these may aid in the 
speed and accuracy of the learning process. 
State Abstraction 
The earliest work in reinforcement learning literature that utilized region-based up-
dates to evaluate states exactly appears as (Yee et aI., 1990). The definition of regions in 
this work were based on concepts organized as a hierarchy to classify the states efficiently. 
This hierarchy is optimized by an explanation-based method to yield large, useful regions. 
Dietterich and Flann (Dietterich and Flann, 1997) proposed optimal state abstrac-
tion routines as components embedded in their value iteration algorithms for planning in 
both deterministic and stochastic domains. These methods assume perfect knowledge about 
the environment and create adaptively regions of states to be evaluated by Bellman back-
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ups. The inverse approach to the decision sequence and reflecting backups to value table 
only upon detecting an improvement in the processed state's value are both inherent fea-
tures of conventional dynamic programming, e.g. all-pairs shortest path algorithm (Baase 
and van Gelder, 1999). These methods were demonstrated on a grid maze (i.e. 2D state 
representation) and the regions were rectangular. Experiments verified the expectation that 
regional backups accelerate learning. 
An attempt to generalize Bellman backups to handle relational logic operators was 
made recently in (Kersting et aI., 2004). In particular, this work defines abstract versions 
of the components of conventional reinforcement learning by means oflogical queries and 
then derives a Bellman operator to evolve these rules to express efficiently the pre-image 
of an action that gives rise to a particular state. 
These works aim at accelerating learning by making use of some sort of a built-in 
procedure to maximize the regions to be updated. However, they allow no manipulation 
from the exterior in forming these regions, which are presumably optimally large under 
some assumptions on the domain. 
From the point of view of this work, such views to state abstraction tend to relate to 
hierarchical methods of reinforcement learning eventually, as they draw generalizations on 
the state space in unsupervised ways. 
Other Forms of Advice 
Guiding reinforcement learning with external knowledge has been a major issue for 
over a decade. Many researchers have adopted the term advice to name this knowledge 
provided/imposed by an external source. Two natural problems arising in dealing with 
advice are how to represent it and where to incorporate it in the learning system. 
Maclin and Shavlik touched these problems (arguably the former one more than 
the latter) in (Maclin and Shavlik, 1996). They actually proposed a reinforcement learning 
system, called RATLE, which requests advice from an external observer and assimilates 
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the provided information in its internal connectionist structure. In a parallel direction, an 
actor/critic learning scheme augmented with an explicit supervisor is presented in (Rosen-
stein and Barto, 2004). This study addresses the issue of combining supervisor knowledge 
with reinforcement signal in an optimal way. These two works present and delineate very 
sound scenarios of utilizing advice, which is provided on-the-fly, not a priori. 
The works (Ng et al., 1999) and (Wiewiora et al., 2003) propose a computational 
method to utilize prior knowledge in Q-Iearning. This is achieved by adding a static and 
real-valued potentialfunction of the encountered state/action pair to the right-hand side of 
the conventional Q-value iteration. Ng et. al. enlighten in (Wiewiora et al., 2003) the mild 
conditions under which this modification does not alter the optimal policy so that the effect 
of.potential function is limited to injecting prior knowledge. The latter work generalizes 
the potential function to accommodate state transitions, i.e. the 4-tuple (s, a, s', a'), rather 
than state/action pairs. 
Using potential function is an elegant way of guiding the search of useful actions 
with prior knowledge. Employing a fixed value representing prior knowledge in the recur-
sion is a significant extension of setting an initial Q-Iandscape, which can convey the prior 
knowledge only temporarily. However, introducing a bias to the iteration as suggested by 
this function still necessitates a careful fine-tuning of the iteration parameters, because it 
involves the magnitude of Q-updates. 
Suggested Abstraction Scheme 
This study suggests a predefined partition of state/action space into groups such 
that the experience gained by an instance (in the form of state transition Xk ~ Xk+l and 
corresponding reward) routes the value updates of all elements in the group. Note that it is 
actually the form of partitioning of the state/action pairs that represents the prior knowledge 
about the problem. 
The following example demonstrates the basic idea underlying the suggested state 
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abstraction scheme, which is customizes next for the anemia management problem. 
An Example 
Consider Markov decision process with finite state and action spaces S and A, 
but with incomplete transition information, andQ-Iearning will be applied to discover the 
optimal policy. 
Suppose also that S and A are both partially ordered sets and that it is known in 
advance that the policy p(.) : S ---+ A governing this process optimally is non-increasing. 
This information inherent in the problem implies that, if the action part of an encountered 
state/action pair (x*, a*) is evaluated as being unfavorable because of its insufficiency with 
respect to the control objective in effect at some point, then the action portions of all pairs 
Q(x*, a*) = {(x*, a), a E A : a < a*} could be classified in this way. It is then reason-
able to apply the value iteration to all members ofQ(x*, a*) in parallel with the one for the 
individual pair (x*, a*), resulting in decrements in all their values by amounts determined 
by the temporal difference iteration. Excluding the exploration mechanism from the dis-
cussion, such a group update would reduce the chance of actions a < a* being selected in 
future visits to x* (as it is already known -due to the prior knowledge- that those actions 
would really be non-beneficial). 
State Abstraction Due to Monotonicity 
The particular information utilized in the drug dosing problem is that any admissible 
drug dosing policy exploits a monotonically non-decreasing relationship between the EPO 
dose and the HGB level. This fact validates routing the Q-value updates upon the state 
transition Xk --t Xk+l due to the action ak in this way: 
• If 11.5 > Xk 2: Xk+l or Xk = 11.5 > Xk+}, then add the temporal difference, i.e. 
the second term on the right-hand side (16), not only to Q(Xk, ak) but also to all 
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{Q(x,a): x < xk,a < ad 
• Else, if Xk+l 2:- Xk > 11.5 or Xk+l > Xk = 11.5, then add the temporal difference, 
i.e. the second term on the right-hand side (16), not only to Q(Xk, ak) but also to all 
{Q(Xb a): X> Xk,a > ad 
• Else, perform the basic Q-update (16) on Q(Xk, ak) only. 
Note that the new update scheme punishes a group of state/action pairs whenever 
the system exploits an undesired state transition so that the group of actions, which are 
certainly unfavorable in the light of the monotonicity information. As a result, such actions 
are less likely to be taken in further decision instances, so the learning speed is expected to 
improve with the proposed modification. 
Experimental Evaluation 
The proposed extension was evaulated using an experimental setup similar to the 
ones used in Section ry.B. An artificial population of 100 normal responders and 100 poor 
responders was created first. For each artificial patient, a set of four initial HOB values 
was generated based on the statistics from the above mentioned patient data from 186 
individuals. The considered drug dosing mechanism was the one used in Section IY.B, 
i.e. the discrete-time control system in Figure 9. The difference from the plain Q-Ieaming 
method here is the suggested abstraction scheme developed above. 
In the first set of simulations, plain Q-Iearning, i.e. the one without group Q-
updates, was applied. Subsequently, the simulations were repeated using the proposed 
extended Q-Iearning algorithm that includes group updates using the same experimental 
conditions. The evaluation process was completed by simulating the anemia treatment 
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Figure 14. HGB level and EPO dose for an individual normal responder as performed by 
plain Q-Ieaming. 
Results on Individuals 
Figures 14 and 15 show examples of a simulated anemia treatment performed by 
the plain Q-Ieaming for a representative normal and poor responder, respectively. These 
figures, similar to the ones in Figures 10 and 12, demonstrate that the standard Q-Ieaming 
exhibits a tendency to maintain the HGB level close to the upper bound of the target range 
in normal responders and close to the lower bound of the target range in poor responders. 
Figures 16 and 17 show examples of a simulated anemia treatment performed by 
the extended Q-Ieaming method with group updates for a representative normal and poor 
responder, respectively. These figures show that the addition of group updates allows for 
much better control of HGB level. For both, normal and poor responder, the HGB level is 
now much closer to the median of the target range. Hence, one would expect this method 
to be more effective than the classical Q-Ieaming in a real clinical environment. 
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Figure 16. HGB level and EPO dose for an individual normal responder as performed by 









Figure 17. HGB level and EPO dose for an individual poor responder as performed by 
Q-learning with group updates. 
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Figure 18. HGB level and EPa dose for an individual normal responder as performed by 
AMP. 
Finally, Figures 18 and 19 show examples of a simulated anemia treatment per-
formed by the numerically implemented Anemia Management Protocol. The most striking 
phenomenon that can be observed in these figures is the HGB level fluctuation within the 
target range. This fluctuation occurs for both types of responders. This observation in the 
simulated environment is consistent with actual data from the clinical environment. 
Statistical Results 
Tables 4 and 5 provide a quantitative comparison between the three simulated meth-
ods. The results are reported as means and 95% Confidence Intervals. Comparing the 
mean HGB levels of normal responders between the three methods, one can observe that 
Q-leaming has a tendency to overshoot the HGB level, whereas Q-leaming with group up-









Figure 19. HOB level and EPa dose for an individual poor responder as perfonned by 
AMP. 
target range. Comparing the standard deviations of HOB levels for nonnal responders be-
tween the three methods, one can observe that both Q-Iearning methods provide for more 
stable HOB control than the Anemia Management Protocol. Due to the inability of Q-
learning to maintain the HOB level within the target range, the third criterion (number of 
times HOB out of target range) has a much larger value for this method, compared to the 
other two. The amounts of administered EPa are not significantly different between the 
three methods. 
Comparing the mean HOB levels of poor responders between the three methods, 
one can observe that all three methods are capable of driving the HOB level to the target 
range. Comparison between the standard deviations of HOB levels reveals that, similarly 
as in the case of nonnal responders, Q-Ieaming methods provide more stable HOB control 
than the Anemia Management Protocol. In tenns of the number oftimes the HOB level was 
out of target range, Q-Iearning with group updates outperfonns the other two competitors. 
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Table 4 
Statistical Comparison of Anemia Management Methods on Normal Responders 
Treatment Plain Q-leaming 
Method Q-Ieaming Group Update AMP 
MeanHGB 12.21 11.77 11.75 
(g/dL) (11.77,12.64) (11.51,12.02) (11.47,12.02) 
StdDev HGB 0.16 0.25 0.50 
(g/dL) (0.06,0.26) (0.09,0.40) (0.30,0.70) 
Total EPO 286.3 227.8 223.2 
(1,000 U) (200.2,372.5) (122.3,333.3) (116.9,329.6) 
Table 5 
Statistical Comparison of Anemia Management Methods on Poor Responders 
Treatment Plain Q-Ieaming 
Method Q-learning Group Update AMP 
MeanHGB 11.44 11.46 11.56 
(g/dL) (10.69,11.91) (11.18,11.73) (11.34,11.77) 
StdDevHGB 0.26 0.26 0.58 
(g/dL) (0.14,0.37) (0.12,0.39) (0.28,0.87) 
Total EPO 468.1 469.7 474.9 
(1,000 U) (351.2,585.1) (334.3,605.3) (351.2,585.1) 
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This study is presumably the first attempt in formulating a medical treatment pro-
cess as a model-free approximate dynamic programming instance, and casting reinforce-
ment learning methods for solution. 
Having chosen the anemia management as the test-bed, the optimal dmg-dosing 
policies of individual virtual patients have been retrieved successfully by using two well-
known reinforcement learning methods SARSA and Q-Iearning. To achieve the control 
task using these methods a particular patient model is not required. The methods process 
only simulated trajectories obtained from patients. For the purpose of generating these 
sample trajectories, a Takagi-Sugeno fuzzy model of an anemia patient has been used in 
the simulative treatment. 
On-policy temporal difference procedure SARSA has been employed first to ex-
tract the optimal drug dosing policies from sample trajectories generated by the patient. 
The results show that the episodic SARSA procedure generates adequate dosing strategies 
for representative individuals from two different response groups, namely normal and poor 
responders. Statistics derived over repeated simulations have confirmed that the obtained 
results were consistent with the clinical goals. To facilitate compact parametric representa-
tion of the Q-table, the use of an R13F network as an approximator has also been explored. 
Initial results showed that it is possible to obtain a convergent RBF approximator for the 
Q-table. 
Implementation of plain Q-learning with RBF network for policy interpolation has 
also been demonstrated. Experimental evaluation has allowed for comparing this method 
against the Anemia Management Protocol, regarded here as the gold standard. Statistical 
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and clinical analysis of the test results have showed that Q-Iearning is actually capable of 
performing adequate anemia treatment in real time, comparable to the Anemia Manage-
ment Protocol. 
Finally, as an extension to the suggested reinforcement learning methods, a novel 
state-abstraction mechanism has been proposed and tested experimentally. The suggested 
approach has incorporated a useful clinical knowledge, namely the monotonicity of dose-
response characteristic, into the simulative solution process. This constitutes a typical il-
lustration of how problem-specific hints could aid substantially in the solution. The benefit 
gained by this addition has revealed itself as a significant improvement in the learning time, 
as simulated in the experiments. 
Results of this study obtained using artificial patients require elaborate inspections 
and many clinical constraints taken into account before they become clinically meaningful 
in practice. Such a medical orient~:d extension is necessary as it would obviously yield a 
fair assessment of the practical value of this research effort. 
As a final word, the author would like to stress his viewpoint that neither model-
free nor model-based approaches alone can be successful enough in simulating and im-
proving medical treatment processes, such as anemia management. Therefore, although 
inaccuracies of patient models in many medical applications were leading the motivations 
of this study, the approaches pres~:nted here could be utilized best in collaboration with 
mainstream biomedical approaches that focus on modeling patients. A useful decision 
mechanism could then be constructed from their constructive trade-off. As an immediate 
application of this approach, a hybrid method weighting the decisions from model-free 
and model-based decision makers is suggested in (Gaweda et al., 2006b), where weights 
assigned to their advices depend on the inaccuracy of the patient model along treatment. 
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